Resources
The latest in from biologics discovery and development through to production and supply chain management.
Through captivating articles, insight pieces, and spotlight interviews, we delve into the remarkable innovations, breakthroughs, and scientific marvels that have defined the landscape of research over the past year.
Biosimilars & Biobetters
FDA's AI Model Enhances Safety of Biosimilar Therapeutic Proteins
Thanks to the FDA's new AI-powered imaging tool, the safety profile of newly developed biosimilar therapeutic protiens may improve.
Biosimilars & Biobetters
Biocon’s Biosimilar Difficulties: Successive FDA Rejections Don’t Inspire Hope
Biocon suffer another FDA rejection due to data and manufacturing concerns, this time for their bevacizumab biosimilar.
Biosimilars & Biobetters
Retinal Disease Drug Receives Approval from European Commission
Ranivisio is a biosimilar of Lucentis which treats serious retinal diseases.
Subscribe to Our Newsletter
Sign up for our monthly newsletter to
keep up with all things biologics